Sesti, Giorgio
Sesti, Giorgio
DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE
2009 SIPREC consensus document executive summary. Cardiovascular prevention in subjects with impaired fasting glucose or impaired glucose tolerance
2010 Volpe, M.; Borghi, C.; Cavallo Perin, P.; Chiariello, M.; Manzato, E.; Miccoli, R.; Modena, M. G.; Riccardi, G.; Sesti, G.; Tiengo, A.; Trimarco, B.; Vanuzzo, D.; Verdecchia, P.; Zaninelli, A.; Del Prato, S.
3'-UTR OLR1/LOX-1 gene polymorphism and endothelial dysfunction: molecular and vascular data in never-treated hypertensive patients
2014 Sciacqua, A; Presta, I; Perticone, M; Tassone, Ej; Andreozzi, F; Quitadamo, Mc; Sangiuolo, Fc; Sesti, G; Perticone,
A bedside ultrasound protocol to the measurement of the systemic vascular resistances: Preliminary results in the patients with sepsis
2023 Martocchia, Antonio; Piccoli, Cinzia; Notarangelo, Michele Fortunato; Bentivegna, Enrico; Sergi, Daniela; Luciani, Michelangelo; Barlattani, Michela; Sesti, Giorgio; Martelletti, Paolo
A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study
2008 Staiger, H; Stan, ; Áková, A; Zilinskaite, J; Vänttinen, M; Hansen, T; Marini, Ma; Hammarstedt, A; Jansson, P-A; Sesti, G; Smith, U; Pedersen, O; Laakso, M; Stefan, N; Fritsche, A; Häring, H-U
A Case Series Report on the Effect of Tofacitinib on Joint Inflammation and Gut Microbiota Composition in Psoriatic Arthritis Patients Naive to Biologic Agents
2024 PICCHIANTI DIAMANTI, Andrea; Panebianco, Concetta; DI GIOIA, Valeria; Bellofatto, ILARIA ANNA; Salemi, Simonetta; DI ROSA, Roberta; Sesti, Giorgio; Nalli, Gabriele; Salerno, Gerardo; Finocchiaro, Etta; Laganà, Bruno
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects
2003 Sesti, G; Cardellini, M; Marini, Ma; Frontoni, S; D'Adamo, M; Del Guerra, S; Lauro, D; De Nicolais, P; Sbraccia, P; Del Prato, S; Gambardella, S; Federici, M; Marchetti, P; Lauro, R
A fasting insulin–raising allele at IGF1 locus is associated with circulating levels of IGF-1 and insulin sensitivity.
2013 Mannino, Gc; Greco, A; De Lorenzo, C; Andreozzi, F; Marini, Ma; Perticone, F; Sesti, G
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with chronic kidney disease
2013 Sesti, G; Mannino, Gc; De Lorenzo, C; Greco, A; Sciacqua, A; Marini, Ma; Andreozzi, F; Perticone, F.
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity
2012 Andreozzi, F; Presta, I; Mannino, Gc; Scarpelli, D; Di Silvestre, S; Di Pietro, N; Succurro, E; Sciacqua, A; Pandolfi, A; Consoli, A; Hribal, Ml; Perticone, F; Sesti, G
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients
2019 Mannino, Gc; Pezzilli, S; Averta, C; Fuoco, A; Spiga, R; Mancuso, E; Di Fatta, C; Perticone, F; Prudente, S; Trischitta, V; Andreozzi, F; Sesti, G
A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks. DUAL VIII, a randomized trial designed to resemble clinical practice
2020 Sesti, G.; Bardtrum, L.; Dagdelen, S.; Halladin, N.; Haluzik, M.; Orsy, P.; Rodriguez, M.; Aroda, V. R.
A Phase 2, randomized, dose-finding study of the novel once-weekly human GLP-1 analog, semaglutide, compared with placebo and open-label liraglutide in patients with type 2 diabetes
2016 Nauck, Ma; Petrie, Jr; Sesti, G; Mannucci, E; Courrèges, Jp; Lindegaard, Ml; Jensen, Cb; Atkin, Sl; Study 1821 Principal, Investigators.
A polymorphism at IGF1 locus is associated with anemia
2017 Marini, Ma; Mannino, Gc; Fiorentino, Tv; Andreozzi, F; Perticone, F; Sesti, G
A polymorphism at IGF1 locus is associated with carotid intima media thickness and endothelium-dependent vasodilatation.
2014 Sesti, G; Mannino, Gc; Andreozzi, F; Greco, A; Perticone, M; Sciacqua, A; Marini, Ma; Perticone, F
A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (Onset 9)
2020 Lane, Wendy S; Favaro, Elena; Rathor, Naveen; Jang, Hak C; Kjærsgaard, Maiken I S; Oviedo, Alejandra; Rose, Ludger; Senior, Peter; Sesti, Giorgio; Soto Gonzalez, Alfonso; Franek, Edward
A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus
2009 Montanya, E; Sesti, G
Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults. A Meta-analysis
2021 Ahuja, Vasudha; Aronen, Pasi; Pramodkumar, T A; Looker, Helen; Chetrit, Angela; Bloigu, Aini H; Juutilainen, Auni; Bianchi, Cristina; La Sala, Lucia; Anjana, Ranjit Mohan; Pradeepa, Rajendra; Venkatesan, Ulagamadesan; Jebarani, Sarvanan; Baskar, Viswanathan; Fiorentino, Teresa Vanessa; Timpel, Patrick; Defronzo, Ralph A; Ceriello, Antonio; Del Prato, Stefano; Abdul-Ghani, Muhammad; Keinänen-Kiukaanniemi, Sirkka; Dankner, Rachel; Bennett, Peter H; Knowler, William C; Schwarz, Peter; Sesti, Giorgio; Oka, Rie; Mohan, Viswanathan; Groop, Leif; Tuomilehto, Jaakko; Ripatti, Samuli; Bergman, Michael; Tuomi, Tiinamaija
Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser(307) and Ser(612) and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells
2004 Andreozzi, F; D'Alessandris, C; Federici, M; Laratta, E; Del Guerra, S; Del Prato, S; Marchetti, P; Lauro, R; Perticone, F; Sesti, G
Additive effect of non-alcoholic fatty liver disease on metabolic syndrome-related endothelial dysfunction in hypertensive patients
2016 Perticone, M; Cimellaro, A; Maio, R; Caroleo, B; Sciacqua, A; Sesti, G; Perticone, F
Alkaline phosphatase affects renal function in never-treated hypertensive patients. effect modification by age
2020 Sciacqua, Angela; Tripepi, Giovanni; Perticone, Maria; Cassano, Velia; Fiorentino, Teresa V.; Pititto, Gerardo N.; Maio, Raffaele; Miceli, Sofia; Andreozzi, Francesco; Sesti, Giorgio; Perticone, Francesco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 2009 SIPREC consensus document executive summary. Cardiovascular prevention in subjects with impaired fasting glucose or impaired glucose tolerance | 2010 | Volpe, M.; Borghi, C.; Cavallo Perin, P.; Chiariello, M.; Manzato, E.; Miccoli, R.; Modena, M. G.; Riccardi, G.; Sesti, G.; Tiengo, A.; Trimarco, B.; Vanuzzo, D.; Verdecchia, P.; Zaninelli, A.; Del Prato, S. | |
| 3'-UTR OLR1/LOX-1 gene polymorphism and endothelial dysfunction: molecular and vascular data in never-treated hypertensive patients | 2014 | Sciacqua, A; Presta, I; Perticone, M; Tassone, Ej; Andreozzi, F; Quitadamo, Mc; Sangiuolo, Fc; Sesti, G; Perticone, | |
| A bedside ultrasound protocol to the measurement of the systemic vascular resistances: Preliminary results in the patients with sepsis | 2023 | Martocchia, Antonio; Piccoli, Cinzia; Notarangelo, Michele Fortunato; Bentivegna, Enrico; Sergi, Daniela; Luciani, Michelangelo; Barlattani, Michela; Sesti, Giorgio; Martelletti, Paolo | |
| A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study | 2008 | Staiger, H; Stan, ; Áková, A; Zilinskaite, J; Vänttinen, M; Hansen, T; Marini, Ma; Hammarstedt, A; Jansson, P-A; Sesti, G; Smith, U; Pedersen, O; Laakso, M; Stefan, N; Fritsche, A; Häring, H-U | |
| A Case Series Report on the Effect of Tofacitinib on Joint Inflammation and Gut Microbiota Composition in Psoriatic Arthritis Patients Naive to Biologic Agents | 2024 | PICCHIANTI DIAMANTI, Andrea; Panebianco, Concetta; DI GIOIA, Valeria; Bellofatto, ILARIA ANNA; Salemi, Simonetta; DI ROSA, Roberta; Sesti, Giorgio; Nalli, Gabriele; Salerno, Gerardo; Finocchiaro, Etta; Laganà, Bruno | |
| A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects | 2003 | Sesti, G; Cardellini, M; Marini, Ma; Frontoni, S; D'Adamo, M; Del Guerra, S; Lauro, D; De Nicolais, P; Sbraccia, P; Del Prato, S; Gambardella, S; Federici, M; Marchetti, P; Lauro, R | |
| A fasting insulin–raising allele at IGF1 locus is associated with circulating levels of IGF-1 and insulin sensitivity. | 2013 | Mannino, Gc; Greco, A; De Lorenzo, C; Andreozzi, F; Marini, Ma; Perticone, F; Sesti, G | |
| A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with chronic kidney disease | 2013 | Sesti, G; Mannino, Gc; De Lorenzo, C; Greco, A; Sciacqua, A; Marini, Ma; Andreozzi, F; Perticone, F. | |
| A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity | 2012 | Andreozzi, F; Presta, I; Mannino, Gc; Scarpelli, D; Di Silvestre, S; Di Pietro, N; Succurro, E; Sciacqua, A; Pandolfi, A; Consoli, A; Hribal, Ml; Perticone, F; Sesti, G | |
| A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients | 2019 | Mannino, Gc; Pezzilli, S; Averta, C; Fuoco, A; Spiga, R; Mancuso, E; Di Fatta, C; Perticone, F; Prudente, S; Trischitta, V; Andreozzi, F; Sesti, G | |
| A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks. DUAL VIII, a randomized trial designed to resemble clinical practice | 2020 | Sesti, G.; Bardtrum, L.; Dagdelen, S.; Halladin, N.; Haluzik, M.; Orsy, P.; Rodriguez, M.; Aroda, V. R. | |
| A Phase 2, randomized, dose-finding study of the novel once-weekly human GLP-1 analog, semaglutide, compared with placebo and open-label liraglutide in patients with type 2 diabetes | 2016 | Nauck, Ma; Petrie, Jr; Sesti, G; Mannucci, E; Courrèges, Jp; Lindegaard, Ml; Jensen, Cb; Atkin, Sl; Study 1821 Principal, Investigators. | |
| A polymorphism at IGF1 locus is associated with anemia | 2017 | Marini, Ma; Mannino, Gc; Fiorentino, Tv; Andreozzi, F; Perticone, F; Sesti, G | |
| A polymorphism at IGF1 locus is associated with carotid intima media thickness and endothelium-dependent vasodilatation. | 2014 | Sesti, G; Mannino, Gc; Andreozzi, F; Greco, A; Perticone, M; Sciacqua, A; Marini, Ma; Perticone, F | |
| A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (Onset 9) | 2020 | Lane, Wendy S; Favaro, Elena; Rathor, Naveen; Jang, Hak C; Kjærsgaard, Maiken I S; Oviedo, Alejandra; Rose, Ludger; Senior, Peter; Sesti, Giorgio; Soto Gonzalez, Alfonso; Franek, Edward | |
| A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus | 2009 | Montanya, E; Sesti, G | |
| Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults. A Meta-analysis | 2021 | Ahuja, Vasudha; Aronen, Pasi; Pramodkumar, T A; Looker, Helen; Chetrit, Angela; Bloigu, Aini H; Juutilainen, Auni; Bianchi, Cristina; La Sala, Lucia; Anjana, Ranjit Mohan; Pradeepa, Rajendra; Venkatesan, Ulagamadesan; Jebarani, Sarvanan; Baskar, Viswanathan; Fiorentino, Teresa Vanessa; Timpel, Patrick; Defronzo, Ralph A; Ceriello, Antonio; Del Prato, Stefano; Abdul-Ghani, Muhammad; Keinänen-Kiukaanniemi, Sirkka; Dankner, Rachel; Bennett, Peter H; Knowler, William C; Schwarz, Peter; Sesti, Giorgio; Oka, Rie; Mohan, Viswanathan; Groop, Leif; Tuomilehto, Jaakko; Ripatti, Samuli; Bergman, Michael; Tuomi, Tiinamaija | |
| Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser(307) and Ser(612) and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells | 2004 | Andreozzi, F; D'Alessandris, C; Federici, M; Laratta, E; Del Guerra, S; Del Prato, S; Marchetti, P; Lauro, R; Perticone, F; Sesti, G | |
| Additive effect of non-alcoholic fatty liver disease on metabolic syndrome-related endothelial dysfunction in hypertensive patients | 2016 | Perticone, M; Cimellaro, A; Maio, R; Caroleo, B; Sciacqua, A; Sesti, G; Perticone, F | |
| Alkaline phosphatase affects renal function in never-treated hypertensive patients. effect modification by age | 2020 | Sciacqua, Angela; Tripepi, Giovanni; Perticone, Maria; Cassano, Velia; Fiorentino, Teresa V.; Pititto, Gerardo N.; Maio, Raffaele; Miceli, Sofia; Andreozzi, Francesco; Sesti, Giorgio; Perticone, Francesco |